Effects of xenoestrogens on T lymphocytes: Modulation of bcl-2, p53, andapoptosis

International Journal of Molecular Sciences

Volumn 4, Issue 2, 2003, Pages 45-61

  Ndebele, Kenneth ^a,b   Tchounwou, Paul B ^a   McMurray, Robert W ^a,b  

^a Jackson State University   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Bisphenol A; Cell cycle; Coumestrol; DDT; T lymphocytes; TCDD; Xenoestrogens

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4,4' ISOPROPYLIDENEDIPHENOL; CHLORPHENOTANE; COUMESTROL; DNA FRAGMENT; ESTRADIOL; ESTROGEN DERIVATIVE; MESSENGER RNA; PHYTOESTROGEN; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG; XENOESTROGEN;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOTOXICITY; LEUKEMIA CELL LINE; PERIPHERAL BLOOD MONONUCLEAR CELL; RNA TRANSCRIPTION; T LYMPHOCYTE;

EID: 2442584805     PISSN: 14220067     EISSN: None     Source Type: Journal    
DOI: 10.3390/i4020045     Document Type: Article

References (60)

1. Whitacre, C.C.; Reingold, S.C.; O'Looney, P.A. Task Force on Gender, Multiple Sclerosis and Autoimmunity. A Gender Gap in Autoimmunity, Science 1999, 283, 1277-1278 and supplementary material at www.sciencemag.org/feature/data/ 983519.shl.
2. Verthelyi, D. Sex hormones as immunomodulators in health and disease. Int. Immunopharmacol. 2001, 1, 983-993.
3. Olsen, N.J.; Kovacs, W.J. Gonadal steroids and immunity. Endocrine. Rev. 1996, 17, 369-384.
4. Fox, H.S. Sex steroids and the immune system. Ciba Foundation Symposium 1995, 191, 203-211.
5. McMurray, R.W. Estrogen, prolactin, and autoimmunity: actions and interactions. Int. Immunopharmacol. 2001, 1, 995-1008.
6. Wolff, M.S. Environmental estrogens. Environ. Health Perspect. 1995, 103(9), 784-785.
7. Safe, S.H. Endocrine disrupters and human health - is there a problem? An update. Environ. Health Perspect. 2000, 108(6), 487-93.
8. Kaiser, J. Endocrine disrupters. Panel cautiously confirms low-dose effects. Science 2000, 290(5492), 695-697.
9. Neubert, D. Vulnerability of the endocrine system to xenobiotic influence. Reg. Toxicol. Pharmacol. 1997, 26, 9-29.
10. Ahmed, S.A.; Hissong, B.D.; Verthelyi, D.; Donner, K.; Becker, K.; Karpuzoglu-Sahin, E. Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ. Health Perspect. 1999, 5, 681-686.
11. Ashby, J. Testing for endocrine disruption post-EDSTAC: extrapolation of low dose rodent effects to humans. Toxicol. Lett. 2001, 120(1-3), 233-242.
12. Crinnion, W.J. Environmental medicine, part one: the human burden of environmental toxins and their common health effects. Altern. Med. Rev. 2000, 5(1), 52-63.
13. Ziegler, J. Environmental "endocrine disrupters" get a global look. J. Natl. Cancer Inst. 1997, 89(16), 1184-1187.
14. Barton, H.A.; Andersen, M.E. Endocrine active compounds: from biology to dose response assessment. Crit. Rev. Toxicol. 1998, 28(4), 363-423.
15. Barton, H.A.; Andersen, M.E. Dose-response assessment strategies for endocrine-active compounds. Regul. Toxicol. Pharmacol. 1997, 25(3), 292-305.
16. Domon, O.E.; McGarrity, L.J.; Bishop, M.; Yoshioka, M.; Chen, J.J.; Morris, S.M. Evaluation of the genotoxicity of the phytoestrogen, coumestrol, in AHH-1 TK(+/-) human lymphoblastoid cells. Mutat. Res. 2001, 474(1-2),129-37.
17. Sakabe, K.; Okuma, M.; Karaki, S.; Matsuura, S.; Yoshida, T.; Aikawa, H.; Izumi, S.; Kayama, F. Inhibitory effect of natural and environmental estrogens on thymic hormone production in thymus epithelial cell culture. Int. J. Immunopharmacol. 1999, 21(12), 861-868.
18. Hiroi, H.; Tsutsumi, O.; Momoeda, M.; Takai, Y.; Osuga, Y.; Taketani, Y. Differential interactions of bisphenol A and 17beta-estradiol with estrogen receptor alpha (ERalpha) and ERbeta. Endocr. J. 1999, 46(6), 773-778.
19. Howdeshell, K.L.; Hotchkiss, A.K.; Thayer, K.A.; Vandenbergh, J.G.; vom Saal, F.S. Exposure to bisphenol A advances puberty. Nature 1999, 401(6755), 763-764.
20. Sakazaki, H.; Ueno, H.; Nakamuro, K. Estrogen receptor alpha in mouse splenic lymphocytes: possible involvement in immunity. Toxicol. Lett. 2002, 133(2-3), 221-229.
21. Tapiero, H.; Ba, G.N.; Tew, K.D. Estrogens and environmental estrogens. Biomed. Pharmacother. 2002, 56(1), 36-44.
22. Street, J.C.; Sharma, R.P. Alteration of induced cellular and humoral immune responses by pesticides and chemicals of environmental concern: quantitative studies of immunosuppression by DDT, aroclor 1254, carbaryl, carbofuran, and methylparathion. Toxicol. Appl. Pharmacol. 1975, 32(3), 587-602.
23. Banerjee, B.D.; Koner, B.C.; Ray, A. Influence of stress on DDT-induced humoral immune responsiveness in mice. Environ. Res. 1997, 74(1), 43-7.
24. Koner, B.C.; Banerjee, B.D.; Ray, A. Organochlorine pesticide-induced oxidative stress and immune suppression in rats. Indian J. Exp. Biol. 1998, 36(4), 395-8.
25. Dees, C.; Askari, M.; Foster, J.S.; Ahamed, S.; Wimalasena, J. DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle. Mol. Carcinog. 1997, 18(2), 107-114.
26. Diel, P.; Olff, S.; Schmidt, S.; Michna, H. Effects of the environmental estrogens bisphenol A, o,p′-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7. J. Steroid. Biochem. Mol. Biol. 2002, 80(1), 61-70.
27. Tebourbi, O.; Rhouma, K.B.; Sakly, M. DDT induces apoptosis in rat thymocytes. Bull. Environ. Contam. Toxicol. 1998, 61(2), 216-223.
28. Rininger, J.A.; Stoffregen, D.A.; Babish, J.G. Murine hepatic p53, RB, and CDK inhibitory protein expression following acute 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) exposure. Chemosphere 1997, 34(5-7), 1557-68.
29. Silverstone, A.E.; Frazier, D.E. Jr.; Fiore, N.C.; Soults, J.A.; Gasiewicz, T.A. Dexamethasone, beta-estradiol, and 2,3,7,8-tetrachlorodibenzo-p- dioxin elicit thymic atrophy through different cellular targets. Toxicol. Appl. Pharmacol. 1994, 126(2), 248-59.
30. Kamath, A.B.; Xu, H.; Nagarkatti, P.S.; Nagarkatti, M. Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo. Toxicol. Appl. Pharmacol. 1997, 142(2), 367-77.
31. Prell, R.A.; Oughton, J.A.; Kerkvliet, N.I. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on anti-CD3-induced changes in T-cell subsets and cytokine production. Int. J. Immunopharmacol. 1995, 17(11), 951-961.
32. Lai, Z.W.; Hundeiker, C.; Gleichmann, E.; Esser, C. Cytokine gene expression during ontogeny in murine thymus on activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 1997, 52(1), 30-37.
33. Jeon, M.S.; Esser, C. The murine IL-2 promoter contains distal regulatory elements responsive to the Ah receptor, a member of the evolutionarily conserved bHLH-PAS transcription factor family. J. Immunol. 2000, 165(12), 6975-6983.
34. Kharat, I.; Saatcioglu, F. Antiestrogenic effects of 2,3,7,8- tetrachlorodibenzo-p-dioxin are mediated by direct transcriptional interference with the liganded estrogen receptor. Cross-talk between aryl hydrocarbon- and estrogen-mediated signaling. J. Biol. Chem. 1996, 271(18), 10533-10537.
35. Hossain, A.; Tsuchiya, S.; Minegishi, M.; Osada, M.; Ikawa, S.; Tezuka, F.A.; Kaji, M.; Konno, T.; Watanabe, M.; Kikuchi, H. The Ah receptor is not involved in 2,3,7,8-tetrachlorodibenzo- p-dioxin-mediated apoptosis in human leukemic T cell lines. J. Biol. Chem. 1998, 273(31), 19853-1958.
36. Blagosklonny, M.V.; Neckers, L.M. Cytostatic and cytotoxic activity of sex steroids against human leukemia cell lines. Cancer Letters 1994, 76, 81.
37. Kincade, P.W.; Medina, K.L.; Smithson, G. Sex hormones as negative regulators of lymphopoiesis. Immunol. Rev. 1994, 37, 119.
38. Jenkins, J.K.; Suwannaroj, S.; Elbourne, K.B.; Ndebele, K.; McMurray, R.W. 17-β-estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of bcl-2 and cyclin A. Internat. J. Immunopharmacol. 2001, 11, 1897-1911.
39. McMurray, R.W.; Suwannaroj, S.; Ndebele, K.; Jenkins, J.K. Differential effects of sex steroids on T and B lymphocytes: modulation of cell cycling, apoptosis, and bcl-2. Pathobiol. 2001, 69, 44-58.
40. McMurray, R.W.; Ndebele, K.; Jenkins, J.K. 17-β-estradiol suppresses IL-2 and IL-2 receptor. Cytokine 2001, 14, 324-333.
41. Nicoletti, I.; Migliorati, G.; Pagliacci, M.C.; Grignani, F.; Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 1991, 139, 271.
42. Cohen, J.J. Programmed cell death in the immune system. Adv. Immunol. 1991, 50, 55.
43. King, K.L.; Cidlowski, J.A. Cell cycle and apoptosis: common pathways to life and death. J. Cell Biochem. 1995, 58, 175.
44. Pagliacci, M.C.; Spinozzi, F.; Migliorati, G.; Fumi, G.; Smacchia, M.; Grignani, F.; Riccardi, C.; Nicoletti, I. Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. Eur. J. Cancer 1993, 29A(11), 1573-1577.
45. Neumann, C.M.; Oughton, J.A.; Kerkvliet, N.I. Anti-CD3-induced T-cell activation-II. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Intenat. J. Immunopharmacol. 1993, 15(4), 543-550.
46. Huang, D.C.; O'Reilly, L.A.; Strasser, A.; Cory, S. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO Journal 1997, 16, 4628-4635.
47. Kannan, K.; Holcombe, R.F.; Jain, S.K.; Alvarez-Hernandez, X.; Chervenak, R.; Wolf, R.E.; Glass, J. Evidence for the induction of apoptosis by endosulfan in a human T-cell leukemic line. Mol. Cell. Biochem. 2000, 205(1-2), 53-66.
48. Roy, D.; Palangat, M.; Chen, C.W.; Thomas, R.D.; Colerangle, J.; Atkinson, A.; Yan, Z.J. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. J. Toxicol. Environ. Health 1997, 50(1), 1-29.
49. Rininger, J.A.; Stoffregen, D.A.; Babish, J.G. Murine hepatic p53, RB, and CDK inhibitory protein expression following acute 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) exposure. Chemosphere 1997, 34(5-7), 1557-68.
50. Burow, M.E.; Tang, Y.; Collins-Burow, B.M.; Krajewski, S.; Reed, J.C.; McLachlan, J.A.; Beckman, B.S. Effects of environmental estrogens on tumor necrosis factor alpha-mediated apoptosis in MCF-7 cells. Carcinogenesis 1999, 20(11), 2057-61.
51. Payne, J.; Rajapakse, N.; Wilkins, M.; Kortenkamp, A. Prediciton and assessment of the effects of ixtures of four xenoestrogens. Env. Health Perspect. 2000, 108, 983-987.
52. Hughes, C.C.W.; Pober, J.S. Transcriptional regulation of the interleukin-2 gene in normal human peripheral blood T cells. J. Biol. Chem. 1996, 271, 5369-5377.
53. Weiss, A.; Wiskocil, R.L.; Stobo, J.D. The role of T3 surface molecules in the activation of human T cells: A two stimulus requirement for IL-2 production reflects events occurring at a pre-translational level. J. Immunol, 1984, 133, 123-128.
54. Landegren, U.; Andersson, J.; Wigzell, H. Analysis of human T lymphocyte activation in a T cell tumor model system. Eur. J. Immunol. 1985, 15, 308-311.
55. Weiss, A.; Littman, D.R. Signal transduction by lymphocyte antigen receptors. Cell 1994, 76, 263-274.
56. Sutherland, R.L.; Hamilton, J.A.; Sweeney, K.J.E.; Watts, C.K.; Musgrove, E.A. Steroidal regulation of the cell cycle. Ciba Foundation Symposium 1995, 191, 218.
57. McDonnell, D.P.; Dana, S.L.; Hoener, P.A.; Lieberman, B.A.; Imhof, M.O.; Stein, R.B. Cellular mechanisms which distinguish between hormone and antihormone activated estrogen receptor. Ann. New York Acad. Sci. 1995, 761, 121-137.
58. Staples, J.E.; Fiore, N.C.; Frazier, D.E. Jr.; Gasiewicz, T.A.; Silverstone, A.E. Overexpression of the anti-apoptotic oncogene, bcl-2, in the thymus does not prevent thymic atrophy induced by estradiol or 2,3,7, 8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 1998, 151(1), 200-210.
59. Sohoni, P.; Sumpter, J.P. Several environmental oestrogens are also anti-androgens. J. Endocrinol. 1998, 158(3), 327-39.
60. Jordan, V.C.; Lieberman, M.E. Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structure. Mol. Pharmacol. 1984, 26(2), 279-85.